Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer [Phase 2]
A Phase II clinical trial is evaluating laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer, with rec…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy [NA]
Completed clinical trial evaluating a novel dose adjustment algorithm to prevent cytopenia-related delays during FOLFOX chemotherapy; result…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers [NA]
A UCSF-led clinical trial is evaluating radiation therapy for metastatic gastrointestinal cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Endoscopic Resection of Gastrointestinal Neoplasms
Clinical trial update indicating ongoing recruitment for endoscopic resection techniques (EMR and ESD) to treat gastrointestinal neoplasms.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer [Phase 2]
Phase 2 trial evaluating conversion therapy with Fruquintinib plus Sintilimab and the SOX regimen in unresectable gastric cancer is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-10-02Clinical Trial Update: Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors [Phase 1, Phase 2]
Clinical trial update for a phase 1/2 autologous and allogeneic whole cell cancer vaccine in metastatic tumors, currently recruiting across …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors [Phase 1]
This update covers a Phase 1 trial of a CAR-T therapy targeting carcinoembryonic antigen (CEA) for CEA-positive advanced solid tumors, curre…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB [NA]
A completed clinical trial assessing the necessity of ME-NBI targeted biopsy versus standard endoscopic biopsy for early gastric cancer.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions [NA]
ClinicalTrials.gov entry for a predictive model using narrow band imaging to identify early gastric cancer lesions; the study is currently n…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma
A clinical trial evaluating the efficacy of CT041 in sequential treatment after first-line therapy for advanced gastric cancer and gastroeso…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET [Phase 1]
Phase 1 study of TPX-0022 in patients with advanced MET-altered solid tumors, including non-small cell lung cancer and gastric cancer; the t…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Peri-habilitation for Patients With Gastric Cancer [NA]
This clinical trial update describes a peri-habilitation program for gastric cancer patients. The study status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial is exploring RC48-ADC in combination therapies as first-line treatment for advanced/metastatic gastric cancer; th…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
This clinical trial compares endoscopic biopsy with postoperative specimens for molecular diagnosis of gastric cancer and is currently recru…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors [Phase 2]
Phase 2 clinical trial update for SI-B003, BL-B01D1+SI-B003, and BL-B01D1+PD-1 monoclonal antibody in locally advanced or metastatic esophag…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a conversion therapy combining RC48 (disitamab vedotin), sintilimab, and SOX (S-1 and oxaliplatin) fo…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 trial evaluating FLX475 in combination with pembrolizumab for advanced or metastatic gastric cancer has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer [NA]
A completed clinical trial evaluated the combination of PIPAC and FOLFOX for gastric cancer with peritoneal carcinomatosis.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy
A completed clinical trial update describes integrating multi-omics data to improve prognosis prediction for gastric cancer patients after n…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating first-line EXL01 with nivolumab and FOLFOX for PD-L1 CPS ≥5 metastatic gastric cancer and is currently recruit…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors
This clinical trial update describes an ongoing study to understand how frailty-related dietary behaviors change over time in older gastric …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer [NA]
Multicenter clinical trial evaluating laparoscopic total gastrectomy for advanced gastric cancer, currently recruiting at Shanghai Zhongshan…